1Dzik WH, Szczepiorkowski ZM. Leukocyte reduced Products,//Hillyer C, Silberstein LE, Ness PM, et al. Blood Banking and Trans-fusion Medicine: Basic principles & Practice. PA, Churchill Livingstone, 2003:219 - 240
2Roush KS. Febrile, allergic, and other noninfections transfusion reac- tions, in : Hillyer C, Silberstein LE, Ness PM, et al : Blood Banking and Transfusion Medicine: Basic principles & Practice. Philadelphia, PA, Churchill Livingstone, 2003:401 -411
4van Marwijk Kooy M, van Prooijen HC, Moes M, et al. Use of leukocyte-depleted platelet concentrates for the prevention of refractoriness and primary HLA alloimmunization: a prospective, randomized trial [ J]. Blood, 1991, 77 ( 1 ) : 201-205.
5Oksanen K, Kekomaki R, Ruutu T, et al. Prevention of alloimmunization in patients with acute leukemia by use of white cell-reduced blood components- a randomized trial [ J ]. Transfusion, 1991, 31 (7) :588-594.
6Williamson LM, Wimperis JZ, Williamson P, et al. Bedside filtration of blood products in the prevention of HLA alloim- munization-a prospective randomized study [ J ]. Alloimmunisation Study Group. Blood, 1994, 83(10):3028-3035.
7Sintnicolaas K, van Marwijk Kooij M, van Prooijen HC, et al. Leukocyte depletion of random single-donor platelet transfusions does not prevent secondary human leukocyte antigen-alloimmunization and refractoriness: a randomized prospective study [ J]. Blood, 1995, 85 (3) :824-828.
8The Trial to Reduce Alloimmunization to Platelets Study Group. Leukocyte reduction and ultraviolet B irradiation of platelets to prevent alloimmunization and refractoriness to platelet transfusions [ J]. N Engl J Med, 1997, 337 (26) : 1861-1569.
9Seftel MD, Growe GH, Petraszko T, et al. Universal prestorage leukoreduction in Canada decreases platelet alloimmunization and refractoriness [ J ]. Blood, 2004, 103 ( 1 ) :333-339.
